91 results
Page 4 of 5
8-K
EX-1.1
7201agok7r 1i2fr4qt
25 Jun 14
Entry into a Material Definitive Agreement
12:00am
424B5
qhnf0 n0706z60x
25 Jun 14
Prospectus supplement for primary offering
12:00am
424B5
1g2wg52m9 it
23 Jun 14
Prospectus supplement for primary offering
12:00am
424B3
916sjarlgsnpttgj
29 Jan 14
Prospectus supplement
12:00am
8-K
EX-1.1
be3atvc0aaakao
29 Jan 14
Entry into a Material Definitive Agreement
12:00am
424B3
9mpqgnlhlhd98z5hpr2
27 Jan 14
Prospectus supplement
12:00am
424B4
edvqx 4nhpff3vk73
3 Oct 13
Prospectus supplement with pricing info
12:00am
S-1/A
6m6z3ews8
30 Sep 13
IPO registration (amended)
12:00am
S-1/A
EX-1.1
7m02ttjkqp1r4dqe
30 Sep 13
IPO registration (amended)
12:00am
S-1
an7lby hmorpmtke57
17 Sep 13
IPO registration
12:00am
8-K
EX-99.1
6910oingl3qn
23 Apr 13
First Patient Dosed in Phase I Study of Prothena’s Therapeutic Antibody for Treatment of AL Amyloidosis
12:00am